Drug Type Small molecule drug |
Synonyms Voriconazole/anidulafungin |
Action inhibitors |
Mechanism 1,3-beta-glucan synthase inhibitors, CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14F3N5O |
InChIKeyBCEHBSKCWLPMDN-MGPLVRAMSA-N |
CAS Registry137234-62-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Aspergillosis | Phase 3 | South America | - | |
Aspergillosis | Phase 3 | Canada | - | |
Aspergillosis | Phase 3 | United States | - | |
Aspergillosis | Phase 3 | Europe | - | |
Aspergillosis | Phase 3 | Australia | - | |
Aspergillosis | Phase 3 | Asia | - |